ENDRA Life Sciences Inc.
NDRA· Nasdaq
NDRAENDRA Life Sciences Inc.
Who holds ENDRA Life Sciences Inc., from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Altium Capital Management LLC | 59.3K | +14.2% | $315.9K | 0.7% | Aug 12, 2026 |
| Citadel Advisors LLC | 29.9K | New | $159.5K | 0% | Sep 2, 2026 |
| Citizens Financial Group Inc | 28.4K | New | $151.4K | 0.1% | Aug 7, 2026 |
| Geode Capital Management, LLC | 14.9K | −29.3% | $79.5K | 0% | Aug 12, 2026 |
| Vanguard Fiduciary Trust Co | 10.1K | ±0% | $53.9K | 0% | Aug 13, 2026 |
| Vanguard Capital Management LLC | 7.3K | +160.6% | $39.1K | 0% | Aug 13, 2026 |
| Morgan Stanley | 3.5K | ±0% | $18.9K | 0% | Aug 13, 2026 |
| UBS Group AG | 68 | −55.3% | $362 | 0% | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 58 | New | $309 | 0% | Aug 11, 2026 |
| Northwestern Mutual Wealth Management Co | 19 | ±0% | $101 | 0% | Aug 12, 2026 |
